CVS Health Debt Securities, Available-for-Sale, Amortized Cost, after Allowance for Credit Loss increased by 3.9% to $27.71B in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 4.8%, from $26.43B to $27.71B. Over 3 years (FY 2021 to FY 2024), Debt Securities, Available-for-Sale, Amortized Cost, after Allowance for Credit Loss shows an upward trend with a 6.2% CAGR.
other_debt_securities_available_for_sale_amortized_cost__4a59ca| Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $22.17B | $22.80B | $22.20B | $22.24B | $22.06B | $22.11B | $22.27B | $22.10B | $22.28B | $23.31B | $24.55B | $26.43B | $26.56B | $26.35B | $26.66B | $27.71B |
| QoQ Change | — | +2.8% | -2.6% | +0.2% | -0.8% | +0.2% | +0.7% | -0.7% | +0.8% | +4.6% | +5.3% | +7.7% | +0.5% | -0.8% | +1.2% | +3.9% |
| YoY Change | — | — | — | — | -0.5% | -3.0% | +0.3% | -0.6% | +1.0% | +5.4% | +10.2% | +19.6% | +19.2% | +13.0% | +8.6% | +4.8% |